BackComera Life Sciences Holdings Overview

Comera Life Sciences Holdings Research & Development

Research & Development expenses for CMRA.

Quarterly R&D Expenses

$366015.00
↓ 7.29% YoY

As of Sep 30, 2023

Annual R&D Expenses (TTM)

$1.43M
↓ 17.59% YoY

Trailing 12 months ending Sep 30, 2023

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin